Search

everythinglearnresearchcommunity

for

Search:↓

Udenafil may help hair grow by activating certain stem cells.

Lisinopril, a heart medication, probably caused hair loss in a patient, which stopped after switching drugs.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Gefitinib can cause hair and eyebrow darkening.

Dihydrotestosterone (DHT) worsens heart enlargement, and blocking it may help prevent heart issues.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

Alopecia areata treatments should be personalized, using options like steroids, JAK inhibitors, and other therapies based on individual needs.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

Male pattern baldness is mainly caused by genetics and hormones, treatable with minoxidil and finasteride.

Finasteride reduces hair loss by blocking testosterone's effects on scalp cells.

NGF and minoxidil promote hair growth, while 17 beta-E2 inhibits it.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

Early, tailored assessment and treatment are crucial for adolescent hair loss, with promising new diagnostic and treatment options.

Vitiligo is a systemic disease with psychological effects, and new treatments focus on personalized care.

Dupilumab may worsen hair loss in patients with alopecia areata.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatments.

Janus kinase inhibitors show promise for treating alopecia areata in children.

New treatments for Alopecia Areata, like JAK inhibitors, are effective, and future research is exploring advanced therapies.

JAK inhibitors show promise for treating Alopecia Areata, but more research is needed for better, accessible treatments.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

IGFBP-rP1 could be a new treatment for a common type of hair loss.